Abstract
Previous research has demonstrated that adults with comorbid depressive and anxiety disorders are significantly more likely to show pathological use of drugs or alcohol. Few studies, however, have examined associations of this type in children. A better understanding of the relationships between affective disorders and substance experimentation in childhood could help clarify the complex ways in which pathological substance use symptoms develop early in life. The present study included 11,785 children (Mage = 9.9) participating in the Adolescent Brain Cognitive Development (ABCD) study. Depressive and anxiety disorder diagnoses were evaluated as concurrent predictors of experimentation with alcohol and tobacco. A series of linear regressions revealed that children with either depressive or anxiety disorders were significantly more likely to experiment with alcohol or tobacco. However, children with both depressive and anxiety diagnoses were not more likely to experiment than children without a diagnosis. These results suggest that anxiety or depressive diagnoses in childhood may be associated with a greater likelihood of substance experimentation, but severe psychological distress may suppress these effects.
Funder
T32
P30
Kaminsky Undergraduate Research Award
Publisher
Public Library of Science (PLoS)
Reference55 articles.
1. Pharmaceutical overdose deaths, United States, 2010;C. M. Jones;The Journal of the American Medical Association,2013
2. Global Health Estimates 2016: Disease burden by Cause, Age, Sex, by Country and by Region, 2000–2016;World Health Organization,2018
3. Diagnosis and pharmacotherapy of alcohol use disorder: A review;H. R. Kranzler;JAMA,2018
4. Association between recreational marijuana legalization in the United States and changes in marijuana use and cannabis use disorder from 2008 to 2016;M. Cerdá;JAMA Psychiatry,2020
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献